CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is a hereditary small vessel disease caused by NOTCH3 mutations. Treatment focuses on stroke prevention, symptom management, and lifestyle modifications, as no disease-modifying therapy exists currently.
¶ Aspirin and Antiplatelet Agents
Antiplatelet therapy is a cornerstone of CADASIL management to reduce ischemic stroke risk:
- Low-dose aspirin (81-100 mg daily) is commonly prescribed for primary and secondary stroke prevention ^2
- Clopidogrel may be used in patients who cannot tolerate aspirin
- Dipyridamole combined with aspirin has been studied but evidence specific to CADASIL is limited
- Dual antiplatelet therapy (aspirin + clopidogrel) may be considered after an acute ischemic event, but bleeding risk must be carefully evaluated
- Antiplatelet therapy should be individualized based on stroke history, bleeding risk, and comorbidities
- Some CADASIL patients may have increased susceptibility to intracranial hemorrhage, particularly with cerebral microbleeds on MRI ^3
Rigorous blood pressure control is essential:
- Target blood pressure: <130/80 mmHg according to most guidelines
- First-line agents: ACE inhibitors, ARBs, calcium channel blockers
- Avoid excessive hypotension which may worsen cerebral hypoperfusion
- Regular monitoring and aggressive treatment of hypertension
- Hyperlipidemia: Statin therapy may be considered ^4
- Diabetes management: Tight glycemic control
- Smoking cessation: Absolute contraindication
- Alcohol moderation: Limited alcohol intake
- Weight management: Maintain healthy BMI
Migraine with aura is a common presenting symptom in CADASIL:
- Triptans (sumatriptan, rizatriptan) may be used with caution
- NSAIDs (ibuprofen, naproxen) for acute attacks
- Antiemetics (metoclopramide) for associated nausea
- Beta-blockers (propranolol, metoprolol) - first-line prophylactic agents
- Topiramate - effective for migraine prevention
- Amitriptyline - tricyclic antidepressant with migraine prophylactic properties
- CGRP inhibitors (erenumab, fremanezumab) - newer options with emerging evidence ^5
- Avoid estrogen-containing contraceptives due to increased stroke risk
- Migraine aura may be triggered by certain medications or dehydration
No treatments are FDA-approved specifically for CADASIL-related cognitive decline, but the following may help:
- Cognitive rehabilitation and mental stimulation
- Physical exercise - regular aerobic activity
- Social engagement and occupational therapy
- Sleep hygiene - addressing sleep disorders
Mood and behavioral changes are common in CADASIL:
- Selective serotonin reuptake inhibitors (SSRIs) for depression and anxiety
- Sertraline, citalopram, or escitalopram are commonly used
- Atypical antipsychotics (quetiapine) for severe behavioral changes - use with caution due to stroke risk
- Immediate medical evaluation required
- Consider thrombolysis if within appropriate time window
- Antiplatelet therapy intensification may be needed
- Antiepileptic drugs (levetiracetam, lamotrigine)
- Avoid drugs that lower seizure threshold
- NOTCH3-targeted therapies are under investigation ^6
- Gene therapy approaches targeting NOTCH3 expression
- Stem cell therapies for vascular regeneration
Several clinical trials are investigating novel therapeutics:
- Agents targeting Notch3 signaling pathway
- Vascular protective agents
- Cerebral vasodilators
¶ Lifestyle and Supportive Care
- Regular aerobic exercise (walking, swimming, cycling)
- Aim for 150 minutes of moderate-intensity exercise per week
- Balance and gait training if needed
- Mediterranean diet - associated with reduced cardiovascular risk
- Low sodium intake for blood pressure control
- Adequate hydration
¶ Monitoring and Follow-Up
- Regular neurological examinations
- Annual MRI to monitor disease progression
- Neuropsychological testing for cognitive assessment
- Cardiac evaluation if needed
- Patient education and genetic counseling
- Support groups for CADASIL patients
- Occupational therapy for independence maintenance
- Caregiver support and education